Table 1.
Demographic characteristics, comorbidities, concomitant medications, and adverse events by group.
| Characteristic | HB-adMSCs 100MM, N = 33 | Placebo, N = 15 | Overall, N = 48 |
|---|---|---|---|
| Age (years), M (SD) | 53.2 (17.6) | 54.7 (15.8) | 53.7 (16.9) |
| Sex, n (%) | |||
| Female | 15 (45.5%) | 5 (33.3%) | 20 (41.7%) |
| Male | 18 (54.5%) | 10 (66.7%) | 28 (58.3%) |
| Race, n (%) | |||
| Asian | 1 (3.0%) | 1 (6.7%) | 2 (4.2%) |
| Black or African American | 11 (33.3%) | 3 (20.0%) | 14 (29.2%) |
| White | 21 (63.6%) | 11 (73.3%) | 32 (66.7%) |
| Ethnicity, n (%) | |||
| Hispanic or Latino | 13 (39.4%) | 9 (60.0%) | 22 (45.8%) |
| Not Hispanic or Latino | 20 (60.6%) | 6 (40.0%) | 26 (54.2%) |
| Weight (lbs), M (SD) | 194.6 (48.2) | 194.1 (43.7) | 194.4 (46.3) |
| Height (in), M (SD) | 66.5 (3.5) | 66.1 (4.4) | 66.4 (3.7) |
| BMI, M (SD) | 30.8 (6.3) | 31.2 (5.9) | 30.9 (6.1) |
HB-adMSCs 100MM, allogeneic Hope Biosciences adipose-derived MSCs 1×108 cells.